Mereo BioPharma Group plc
MREO
$2.74
$0.2811.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -47.19M | -43.25M | -45.32M | -36.85M | -26.34M |
| Total Depreciation and Amortization | 1.08M | 1.09M | 1.10M | 1.10M | 1.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.31M | 9.70M | 17.35M | 8.51M | 8.83M |
| Change in Net Operating Assets | 623.00K | -369.00K | -3.33M | 7.22M | -3.47M |
| Cash from Operations | -33.17M | -32.83M | -30.20M | -20.03M | -19.88M |
| Capital Expenditure | -20.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -299.00K | -699.00K | -699.00K | -699.00K | -700.00K |
| Cash from Investing | -319.00K | -699.00K | -699.00K | -699.00K | -700.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | -3.19M | -3.19M |
| Issuance of Common Stock | 47.49M | 47.00M | 47.00M | 58.61M | 11.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -918.00K | -853.00K | -813.00K | -730.00K | -444.00K |
| Cash from Financing | 46.57M | 46.15M | 46.19M | 54.69M | 7.97M |
| Foreign Exchange rate Adjustments | 745.00K | -233.00K | 2.71M | 502.00K | 1.46M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -1.00K | -1.00K | -1.00K |
| Net Change in Cash | 13.82M | 12.38M | 17.99M | 34.46M | -11.15M |